Qiagen
Qiagen, Helix Partner for Hereditary Disease CDx Development
The partnership will leverage Helix's whole-exome sequencing platform and incorporate Qiagen's biopharma relationships, NGS capabilities, and global regulatory expertise.
Top Five Articles on 360Dx Last Week: White House COVID-19 Antigen Testing; LumiraDx; More
Last week, readers were most interested in the White House reopening the nationwide free COVID-19 antigen testing program.
Agilent, Qiagen Nab FDA Approvals for Lung Cancer Treatment CDx
Both companion diagnostics are for use with Mirati Therapeutics' Krazati, a treatment for patients with advanced non-small cell lung cancer.
Qiagen Cites Competitive Advantages in Digital PCR, Sequencing Assays as Part of Core Growth Plan
Premium
On a call with investors to discuss third quarter results, the firm also offered updates on its syndromic testing and NeuMoDx businesses.
Qiagen Reports Double-Digit Q3 Non-COVID Sales Growth, Raises FY22 Guidance
The firm beat analyst estimates on the top and bottom lines despite a 7 percent drop in Q3 revenues due primarily to currency effects.